11/06/2015 - 14:30
ROME – Anti–tumor necrosis factor agents have a slight edge over conventional disease-modifying antirheumatic drugs when it comes to helping psoriatic arthritis patients who are having work issues,...
Field of Interest: Rheumatology
Categories:
News Feed: Internal Medicine News - Rheumatology